169 related articles for article (PubMed ID: 36837903)
1. Serum Androgen Metabolites Correlate with Clinical Variables in African and European American Men with Localized, Therapy Naïve Prostate Cancer.
Ramakrishnan S; Kittles RA; Huss WJ; Wang J; Attwood K; Woloszynska A
Metabolites; 2023 Feb; 13(2):. PubMed ID: 36837903
[TBL] [Abstract][Full Text] [Related]
2. The Prostate Cancer Androgen Receptor Cistrome in African American Men Associates with Upregulation of Lipid Metabolism and Immune Response.
Berchuck JE; Adib E; Abou Alaiwi S; Dash AK; Shin JN; Lowder D; McColl C; Castro P; Carelli R; Benedetti E; Deng J; Robertson M; Baca SC; Bell C; McClure HM; El Zarif T; Davidsohn MP; Lakshminarayanan G; Rizwan K; Skapura DG; Grimm SL; Davis CM; Ehli EA; Kelleher KM; Seo JH; Mitsiades N; Coarfa C; Pomerantz MM; Loda M; Ittmann M; Freedman ML; Kaochar S
Cancer Res; 2022 Aug; 82(16):2848-2859. PubMed ID: 35731919
[TBL] [Abstract][Full Text] [Related]
3. Association among plasma 1,25(OH)
Ramakrishnan S; Steck SE; Arab L; Zhang H; Bensen JT; Fontham ETH; Johnson CS; Mohler JL; Smith GJ; Su LJ; Woloszynska A
Prostate; 2019 Jul; 79(10):1117-1124. PubMed ID: 31077420
[TBL] [Abstract][Full Text] [Related]
4. Dihydrotestosterone administration does not increase intraprostatic androgen concentrations or alter prostate androgen action in healthy men: a randomized-controlled trial.
Page ST; Lin DW; Mostaghel EA; Marck BT; Wright JL; Wu J; Amory JK; Nelson PS; Matsumoto AM
J Clin Endocrinol Metab; 2011 Feb; 96(2):430-7. PubMed ID: 21177791
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of specific glucuronidated androgen metabolites predict BMD and prostate volume in elderly men.
Vandenput L; Labrie F; Mellström D; Swanson C; Knutsson T; Peeker R; Ljunggren O; Orwoll E; Eriksson AL; Damber JE; Ohlsson C
J Bone Miner Res; 2007 Feb; 22(2):220-7. PubMed ID: 17059374
[TBL] [Abstract][Full Text] [Related]
6. Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada.
Wu AH; Whittemore AS; Kolonel LN; John EM; Gallagher RP; West DW; Hankin J; Teh CZ; Dreon DM; Paffenbarger RS
Cancer Epidemiol Biomarkers Prev; 1995; 4(7):735-41. PubMed ID: 8672990
[TBL] [Abstract][Full Text] [Related]
7. Molecular and pathological subtypes related to prostate cancer disparities and disease outcomes in African American and European American patients.
Mori JO; White J; Elhussin I; Duduyemi BM; Karanam B; Yates C; Wang H
Front Oncol; 2022; 12():928357. PubMed ID: 36033462
[TBL] [Abstract][Full Text] [Related]
8. Androgen quantitation in prostate cancer tissue using liquid chromatography tandem mass spectrometry.
Titus M; Tomer KB
Methods Mol Biol; 2011; 776():47-57. PubMed ID: 21796519
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Prostate Androgens by Megalin and 25-hydroxyvitamin D Status: Mechanism for High Prostate Androgens in African American Men.
Garcia J; Krieger KD; Loitz C; Perez LM; Richards ZA; Helou Y; Kregel S; Celada S; Mesaros CA; Bosland M; Gann PH; Willnow TE; Vander Griend D; Kittles R; Prins GS; Penning T; Nonn L
Cancer Res Commun; 2023 Mar; 3(3):371-382. PubMed ID: 36875158
[TBL] [Abstract][Full Text] [Related]
10. Profiling adrenal 11β-hydroxyandrostenedione metabolites in prostate cancer cells, tissue and plasma: UPC
du Toit T; Bloem LM; Quanson JL; Ehlers R; Serafin AM; Swart AC
J Steroid Biochem Mol Biol; 2017 Feb; 166():54-67. PubMed ID: 27345701
[TBL] [Abstract][Full Text] [Related]
11. Genomic, epigenomic, and transcriptomic signatures of prostate cancer between African American and European American patients.
Stevens C; Hightower A; Buxbaum SG; Falzarano SM; Rhie SK
Front Oncol; 2023; 13():1079037. PubMed ID: 36937425
[TBL] [Abstract][Full Text] [Related]
12. Prostatic tissue testosterone and dihydrotestosterone in African-American and white men.
Marks LS; Hess DL; Dorey FJ; Macairan ML
Urology; 2006 Aug; 68(2):337-41. PubMed ID: 16904448
[TBL] [Abstract][Full Text] [Related]
13. 11β-hydroxyandrostenedione, the product of androstenedione metabolism in the adrenal, is metabolized in LNCaP cells by 5α-reductase yielding 11β-hydroxy-5α-androstanedione.
Swart AC; Schloms L; Storbeck KH; Bloem LM; Toit Td; Quanson JL; Rainey WE; Swart P
J Steroid Biochem Mol Biol; 2013 Nov; 138():132-42. PubMed ID: 23685396
[TBL] [Abstract][Full Text] [Related]
14. Elevation of Stromal-Derived Mediators of Inflammation Promote Prostate Cancer Progression in African-American Men.
Gillard M; Javier R; Ji Y; Zheng SL; Xu J; Brendler CB; Crawford SE; Pierce BL; Griend DJV; Franco OE
Cancer Res; 2018 Nov; 78(21):6134-6145. PubMed ID: 30181178
[TBL] [Abstract][Full Text] [Related]
15. Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer.
Titus MA; Schell MJ; Lih FB; Tomer KB; Mohler JL
Clin Cancer Res; 2005 Jul; 11(13):4653-7. PubMed ID: 16000557
[TBL] [Abstract][Full Text] [Related]
16. Association between cadmium and androgen receptor protein expression differs in prostate tumors of African American and European American men.
Neslund-Dudas CM; McBride RB; Kandegedara A; Rybicki BA; Kryvenko ON; Chitale D; Gupta N; Williamson SR; Rogers CG; Cordon-Cardo C; Rundle AG; Levin AM; Dou QP; Mitra B
J Trace Elem Med Biol; 2018 Jul; 48():233-238. PubMed ID: 29773186
[TBL] [Abstract][Full Text] [Related]
17. GEN GEN: the genomic genetic analysis of androgen-metabolic genes and prostate cancer as a paradigm for the dissection of complex phenotypes.
Reichardt JK
Front Biosci; 1999 Jul; 4():D596-600. PubMed ID: 10417059
[TBL] [Abstract][Full Text] [Related]
18. Serum testosterone and dihydrotestosterone and prostate cancer risk in the placebo arm of the Reduction by Dutasteride of Prostate Cancer Events trial.
Muller RL; Gerber L; Moreira DM; Andriole G; Castro-Santamaria R; Freedland SJ
Eur Urol; 2012 Nov; 62(5):757-64. PubMed ID: 22658758
[TBL] [Abstract][Full Text] [Related]
19. Large-scale profiling of serum metabolites in African American and European American patients with bladder cancer reveals metabolic pathways associated with patient survival.
Vantaku V; Donepudi SR; Piyarathna DWB; Amara CS; Ambati CR; Tang W; Putluri V; Chandrashekar DS; Varambally S; Terris MK; Davies K; Ambs S; Bollag R; Apolo AB; Sreekumar A; Putluri N
Cancer; 2019 Mar; 125(6):921-932. PubMed ID: 30602056
[TBL] [Abstract][Full Text] [Related]
20. Racial differences in the androgen/androgen receptor pathway in prostate cancer.
Pettaway CA
J Natl Med Assoc; 1999 Dec; 91(12):653-60. PubMed ID: 10628124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
